Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The best one is the cream soda
.33 now. i got out at .27 for a small profit after bagging it for about 9 months.
$jsda $0.2419 ^ 0.0099 (4.27%)
Volume: 64,987 @01/06/21 3:46:40 PM EST
They're in Wal Mart.
shes grinding to 40 cents!
Something tells me were going to run to the .30s soon.
$jsda $0.165 ^ 0.008 (5.10%)
Volume: 313,201 @12/11/20 3:59:49 PM EST
Bid Ask Day's Range
0.16 0.17 0.152 - 0.17
7/11 used to have 4 flavors of jsda. They are down to 1. The blue one Wich I noticed was the only one that ever sold anyway...
Absolutely terrible leadership.
Yeah, it's been brutal watching this last downturn. I managed to sell on the uptick but bought back in at like 50 cents because i was enthused about the CBD possibility and really felt Jones could make a comeback riding the re-surging popularity of cane sugar and the fact that everyone is being driven to online marketplaces due to the pandemic. Unfortunately it doesn't look like they've made any efforts to list their products on the online grocery retailers.
It leads me to the conclusion that they're just not especially interested in selling soda. Because it's not like it's hard to ensure your product is selling for a reasonable price on Amazon for example, you can just list it yourself. It'd probably take someone in the office 15-25 minutes to set something up, and yet they don't seem to have done this.
They were handed the opportunity to compete with larger businesses in distribution on a nearly equal level and they absolutely wasted it.
I'll still keep loading up because i feel like a soda company with national distribution alone justifies a 9 million dollar market cap. I just wish they'd do something, ANYTHING.
.135 what a turd
$jsda $0.151 ^ 0.001 (0.67%)
Volume: 163,638 @11/17/20 3:57:18 PM EST
Bid Ask Day's Range
0.14 0.155 0.145 - 0.155
$jsda $0.1541 v -0.0139 (-8.27%)
Volume: 320,293 @11/09/20 3:21:59 PM EST
$jsda $0.1541 v -0.00295 (-1.88%)
Volume: 6,655 @10/30/20 3:18:43 PM EDT
$jsda $0.159 ? 0.0 (0.00%)
Volume: 2,600 @10/23/20 10:04:51 AM EDT
Going back above .20, .30, .40 etc etc... Potential buyout here, JMO.
$jsda $0.1575 v -0.0025 (-1.56%)
Volume: 116,780 @10/02/20 3:52:23 PM EDT
$jsda $0.16775 ^ 0.00025 (0.15%)
Volume: 16,750 @09/29/20 3:42:23 PM EDT
i made money on this before too but went back to the well for more and fell in.
Beginning to think you may be right. Made money on this in the past. Jennifer just couldn't get it done.
still stuck here at .27
what a turd!
$jsda $0.16 v -0.015 (-8.57%)
Volume: 205,743 @08/27/20 11:40:42 AM EDT
$jsda $0.175 ^ 0.002 (1.16%)
Volume: 34,059 @08/26/20 3:34:00 PM EDT
$jsda $0.178 v -0.00445 (-2.44%)
Volume: 46,130 @07/31/20 3:29:00 PM EDT
$jsda $0.184 ^ 0.0025 (1.38%)
Volume: 73,513 @07/29/20 2:30:11 PM EDT
where are you holding here?
dammit. just run to .27 you POS
You know ; Sometimes You have to Look at The CEO. He has allways done what he Said he was going.to do! And the man puts the Right people in Place. He said after FDA meeting that they sent him to phase3. And that he Had to wait until end of June To file IND. Everyone freaked towards the end of June? On june 30 he filed it! The man is not making up a story when he tells us the FDA wanted Bucillamine to Skip Phase 2 and go to phase3 . You can go to FDA web site and punch in Bucillamine. The past research is their. Hence we skipped 2 onto 3. We get no "Respect" because we havent gone up a 1000+% .....Yet!
The FDA Says! Copied From Their Web Site: A clinical hold is rare; instead, FDA often provides comments intended to improve the quality of a clinical trial. In most cases, if FDA is satisfied that the trial meets Federal standards, the applicant is allowed to proceed with the proposed study.
Approval
The FDA review team has 30 days to review the original IND submission. The process protects volunteers who participate in clinical trials from unreasonable and significant risk in clinical trials. FDA responds to IND applications in one of two ways:
Approval to begin clinical trials.
Clinical hold to delay or stop the investigation. FDA can place a clinical hold for specific reasons, including:
Participants are exposed to unreasonable or significant risk.
Investigators are not qualified.
Materials for the volunteer participants are misleading.
The IND application does not include enough information about the trial’s risks.
A clinical hold is rare; instead, FDA often provides comments intended to improve the quality of a clinical trial. In most cases, if FDA is satisfied that the trial meets Federal standards, the applicant is allowed to proceed with the proposed study.
$jsda $0.183 v -0.002 (-1.08%)
Volume: 145,736 @07/17/20 3:29:29 PM EDT
The only "popping" you're gonna hear is the CEO celebrating his next pay check. No plan, no direction, no idea.
$jsda $0.1999 v -0.0001 (-0.05%)
Volume: 125,258 @07/02/20 3:56:38 PM EDT
Waiting forever for a pop here.
Something is happening. Sudden volume here at .20.
123k slapper
Followers
|
91
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1772
|
Created
|
07/01/05
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |